U.S. and U.K. start new strikes versus Houthi web-sites in Yemen

U.S. and U.K. start new strikes versus Houthi web-sites in Yemen


An RAF FGR4 Storm takes off from Royal Air Power (RAF) Akrotiri army airbase in Greek Cypriot to carry out its mission towards the Iranian-backed Houthis in Yemen on January 12, 2024. 

Ministry of Defence | Anadolu | Getty Images

The U.S. and British militaries introduced a clean spherical of strikes against Houthi targets in Yemen Monday, protection officials stated.

The attacks, which had been carried out by manned aircraft and ships, marked the 2nd time the two militaries introduced strikes against Houthi internet sites in Yemen. The final round was on January 11. Since then, the U.S. has struck various Houthi targets on its own.

The Houthis, an Iranian-backed militia team that controls substantial swaths of territory in Yemen, have launched dozens of attacks against commercial ships in the Purple Sea in modern months. The team claims the strikes are in retaliation to Israel’s bombing of Gaza subsequent Hamas’ Oct. 7 attack on Israel.

The violence has even further fueled fears of the conflict in Israel escalating into a regional war.

The U.S. very last 7 days redesignated the Houthis as a terrorist corporation, a go designed to minimize off funding to the rebel group.

The Biden administration experienced taken out the team from the U.S.’s terrorist list shortly right after getting office environment in get to relieve the flow of meals, medication and other help into strife-torn Yemen. 



Source

S&P 500 rises as investors await possible Iran and U.S. ceasefire: Live updates
World

S&P 500 rises as investors await possible Iran and U.S. ceasefire: Live updates

Traders work on the floor of the New York Stock Exchange (NYSE) at the opening bell in New York on April 2, 2026. Charly Triballeau | Afp | Getty Images The S&P 500 rose on Monday following a winning week as oil prices pulled back, with traders weighing the odds that the U.S.-Iran war could […]

Read More
Neurocrine expands into metabolic diseases with .9 billion Soleno buyout
World

Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout

Piotr Swiat | Lightrocket | Getty Images Neurocrine Biosciences will acquire rare-disease drugmaker ⁠Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused ​drugmaker’s expansion into ​metabolic disorders. The deal ​gives Neurocrine access to Vykat XR, the first drug approved in the U.S. to treat hyperphagia associated with Prader-Willi syndrome, […]

Read More
JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets
World

JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets

Jamie Dimon, Chairman and CEO, JPMorganChase, speaks during the Reagan National Defense Forum at the Ronald Reagan Presidential Library in Simi Valley, California, U.S. December 6, 2025. Jonathan Alcorn | Reuters JPMorgan Chase CEO Jamie Dimon is calling for a broad recommitment to American ideals as his bank navigates geopolitical uncertainty, a teetering economy and […]

Read More